title: [Programs for continuing medical education: B session 7. Progress in treatment for hematologic diseases].
authors.forename: Masaaki
authors.initials: M
authors.lastname: Higashihara
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D055808:Drug Discovery / Q000639:trends*; D004502:Education, Medical, Continuing; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy / Q000235:genetics; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000235:genetics; D058990:Molecular Targeted Therapy / Q000639:trends*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000235:genetics; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents